About

Mativa Diagnostics is developing Msight as the world’s first at-home pregnancy test that also flags risks (including ectopic pregnancy, preeclampsia, gestational diabetes, sexually transmitted infections and more) using a graphene nano-sensor-enabled urine device paired with a mobile app for real-time results and telehealth and care options support.